Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

The Lead

Allergan to Cut Hundreds of U.S. Jobs

April 27, 2015 | by Ryan Bushey, Associate Editor | Articles | Comments

A total of 674 staff members have been let go from Allergan’s operations in California so far since 2014. Read more...

TOPICS:
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Nerve Cells, Blood Vessels in Eye ‘Talk’ to Keep Healthy, Experts Say

April 27, 2015 4:35 pm | by Seth Augenstein, Digital Reporter | News | Comments

Nerve cells and blood vessels engage in a chemical discussion to keep healthy and avoid disease, according to a new study. The findings could lead to ways to prevent eyesight loss in diabetes and macular degeneration. Read more...

TOPICS:

Ebola Scare May Inform U.S.'s Response to Bioterrorism

April 27, 2015 2:50 pm | by Seth Augenstein, Digital Reporter | Articles | Comments

Last year’s Ebola scare might provide a blueprint for a response to the unthinkable: a bioterrorist attack in the U.S. Read more...

TOPICS:

Simultaneous Quantitation of Metabolic Hormones

April 27, 2015 1:22 pm | by Tina Rose, Research Scientist; Qiang Xiao, Ph.D., R&D Manager, EMD Millipore Corporation | Articles | Comments

This article describes a new assay panel that helps overcome these challenges. The MILLIPLEX® MAP Human Metabolic Hormone Magnetic Bead Panel (EMD Millipore) enables the simultaneous quantitation of metabolism-relevant analytes, Read more...

TOPICS:
Advertisement

Scientists Use Gene Editing to Correct Mutation in Cystic Fibrosis

April 27, 2015 12:25 pm | News | Comments

Yale researchers successfully corrected the most common mutation in the gene that causes cystic fibrosis, a lethal genetic disorder. Read more..

TOPICS:

TAXIS: Clinical Potential in Combating Antibiotic Resistance

April 27, 2015 12:19 pm | News | Comments

TAXIS Pharmaceuticals, a drug-discovery company focused on developing a new class of antibiotic agents to treat life-threatening, multidrug-resistant bacterial infections, today announced the presentation of data demonstrating the promise of its lead clinical candidate, TXA709, in combating antibiotic resistance. Read more...

Innovation Gives Pregnant Women with Diabetes Round-the-Clock Glucose Control

April 27, 2015 9:02 am | by University of Leeds | News | Comments

Achieving better glucose control in pregnant women with diabetes by using continuous glucose monitoring may help them give birth to healthier children. Read more...

TOPICS:

Final Trial Results of the World's Most Advanced Malaria Vaccine

April 27, 2015 8:58 am | by London School of Hygiene & Tropical Medicine | News | Comments

The results suggest that the vaccine could prevent a substantial number of cases of clinical malaria, especially in areas of high transmission. Read more...

TOPICS:

Persistent Swollen Neck Glands Could Indicate Cancer

April 27, 2015 8:50 am | by University of Exeter | News | Comments

New research has concluded that persistent enlarged lymph glands, found in the neck, should be referred for further investigation when detected in clinic. Read more...

TOPICS:
Advertisement

Weaker Vaccine Causing Whooping Cough Surge

April 27, 2015 8:45 am | by Monash University | News | Comments

A Monash University expert has teamed up with the United States Centers for Disease Control and Prevention to pinpoint the reason behind a surge in whooping cough cases over the past 10 years. Read more....

TOPICS:

Scientists Pinpoint Brain-Swelling Mechanism

April 27, 2015 8:41 am | by University of British Columbia | News | Comments

Discovery paves way for treatments to prevent brain damage or death following head trauma. Read more...

TOPICS:

MedDay Reports Positive Phase 3 Results from MS Drug Study

April 27, 2015 8:37 am | News | Comments

The study demonstrated evidence of the efficacy and safety of MD1003, a highly-concentrated pharmaceutical-grade biotin administered at a dose of 300 mg per day in the treatment of primary and secondary progressive multiple sclerosis, a major area of unmet medical need. Read more....

TOPICS:

Bristol-Myers Gets Positive EMA Opinion for Immunotherapy Drug, Opdivo

April 24, 2015 12:36 pm | by Stephanie Guzowski, Editor | Articles | Comments

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended approval of Bristol-Myers Squibb’s Opdivo today for the treatment of melanoma. Read more..

TOPICS:

FDA Grants Priority Review for AbbVie's Hepatitis C Treatment

April 24, 2015 12:16 pm | News | Comments

AbbVie has announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) and granted priority review for the company's, all-oral, interferon-free, two direct-acting antiviral treatment of ombitasvir, paritaprevir, ritonavir (OBV/PTV/r), with ribavirin (RBV).  Read more...

TOPICS:

J&J Hikes Quarterly Dividend by 7 Percent

April 24, 2015 12:06 pm | by Linda A. Johnson, AP Business Writer | News | Comments

Johnson & Johnson on Thursday said it's raising its quarterly dividend by 7 percent, marking its 53rd straight year of dividend increases. Read more...

TOPICS:

Fragile X Syndrome: Building a Case for an Alternative Treatment Strategy

April 24, 2015 12:01 pm | by Emory Health Sciences | News | Comments

New research strengthens a potential strategy for treating fragile X syndrome, the most common inherited form of intellectual disability. Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading